尔康制药股价震荡下行，融资资金流出压力显现

Group 1 - The stock dynamics of Erkang Pharmaceutical (300267) are primarily focused on trading data and changes in capital flow [1] - As of February 12, 2026, the balance of margin financing and securities lending was 329 million yuan, a decrease of 2.55% from the previous day, indicating short-term outflow pressure [1] - The stock price has shown a downward trend over the past week, with a decline of 13.52% from February 6 to February 13, closing at 3.71 yuan, down from a high of 3.85 yuan on February 6 [1] Group 2 - The trading activity has been volatile, with a turnover rate of 3.67% on February 10, which dropped to 2.27% on February 12 [1] - On February 13, there was a net inflow of main funds amounting to 8.948 million yuan, although large orders showed a net outflow, reflecting market divergence [1]